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Abstract
Drug-induced liver injury (DILI) is a rare cause of liver disease that is difficult to diagnose
due to the lack of a confirmatory test. The Drug-Induced Liver Injury Network (DILIN) was
developed to enroll patients with DILI to understand the clinical outcomes of the disease.
The present study aims to develop a tool to identify patients with DILI for enrollment into the
DILIN study. The use of ICD-10 codes and liver injury terms were used to search the
electronic medical records (EMRs) of patients at the University of Michigan. It was
hypothesized that free-text searching using key words would be superior to the use of ICD-10
codes. Two million patient encounters within a six month window were searched using ICD10 codes related to toxic liver disease. A total of 489 patients were identified and after
manual review 32 cases were confirmed. Using the medical record numbers from the patients
identified in the initial search, six liver injury terms were used to search free-text in the
EMRs. Twelve cases of DILI were identified using “drug-induced liver injury” and none
were found using “hepatotoxicity.” The results of this study showed that it is feasible to
identify prospective DILI cases using ICD-codes and free-text searching of liver injury
terms.
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Chapter 1: Introduction
1.1 Introduction
Drug-induced liver injury (DILI) is an adverse reaction that is largely unexpected
and caused by the administration of a drug or herbal dietary supplement (HDS) (Overby
et al., 2013). In the United States, DILI is the leading cause of acute liver failure (ALF)
and the most common adverse drug reaction (ADR) for medications. About 14 in
100,000 treated patients per year will develop DILI (Bell & Chalasani, 2009; Bjornsson,
Bergmann, Kvaran, & Sigurdur, 2013). Because there is no objective laboratory test to
diagnose DILI, this rate may be even higher. Thus, the Drug-Induced Liver Injury
Network study (DILIN) was developed in 2003 by the National Institute of Diabetes and
Digestive Kidney Diseases (NIDDK) to better understand the natural history, clinical,
environmental, immunological, and genetic risk factors of DILI (Fontana et al., 2009).
Diagnosing DILI is challenging. Many patients are on multiple medications and
herbal dietary supplements. Furthermore, these products are taken at and for different
periods of time. Much medical history, laboratory tests, and exclusion of competing
causes are necessary to provide a more descriptive picture. Because no single lab test
exists to confirm a DILI diagnosis, causality is assessed by experts, based on the above
criteria (Fontana et al., 2013).
With the growing numbers of patients taking medications and herbal dietary
supplements, there is an increasing chance of developing an ADR of DILI (Bell &
Chalasani, 2009). The need to enroll DILI cases into registry studies is of high
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importance so that the etiology and mechanisms of DILI can be better understood and we
can develop ways to treat, diagnose, and prevent DILI.
Traditional methods of screening patients for DILI rely largely on physician
referrals to liver specialists to confirm a DILI diagnosis. With advancements in
technology, data mining in electronic medical records (EMRs) serves as a useful tool to
help identify patients with DILI. Currently, there are no effective methods to screen for
patients with DILI. As more drugs have been approved each year, the number of patients
with drug-induced liver injury has continued to increase (Hayashi & Chalasani, 2015).
One way to search medical records for potential patients is to use the International
Classification of Diseases (ICD) coding system. The ICD codes are commonly used to
code the diagnoses of patients and billing of physician services. It is also used to monitor
the prevalence of diseases. (International Classification of Diseases (ICD-10-CM/PCS)
Transition- Background, 2015).
1.2 Study Purpose
The aim of this study is to develop an efficient, effective and specific screening
method using free-text searching and ICD-10 codes to identify patients with druginduced liver injury prospectively. By developing a searching strategy to identify patients
with DILI, it is hoped that increased enrollment into prospective registries will provide a
better understanding of the etiologies of DILI.
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1.3 Thesis Statement
The current study will aim to develop a simple searching method using free-text
searching of EMRs and ICD-10 codes to identify patients with DILI. An attempt will be
made to answer the following questions:
1.3.1. Specific Aims.
1. Which terms used for a free-text searching algorithm yield the highest results in
identifying the number of probable DILI cases?
2. Does the use of free-text searching methods yield higher positive predictive or
negative predictive values when compared with ICD-10 codes?
3. Are free-text searching methods more or less specific and sensitive when
compared with ICD-codes?
4. Will the development of a free-text searching algorithm increase the number
of subjects enrolled into the Drug-Induced Liver Injury study?
1.3.2. Hypothesis.
Based on current literature, it is expected that free-text searching methods will be
superior in identifying a higher number of probable DILI cases. It is unclear as to which
terms will yield higher results. ICD-10 codes should be more sensitive, specific, and yield
lower positive predictive values (PPV) when compared to free-text searching methods. It
is expected that over time, the number of subjects enrolled in to the DILIN study will
increase; however, this would be dependent on an effective algorithm and would need to
be examined over time to determine its reliability. Therefore, the results of this study may
be limited to aims 1–3.
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Chapter 2: Background
2.1 Background
There is an increasing need for retrieving clinical data for research purposes. The
data can be used for measuring health care quality, monitoring indicators of adverse
events, screening for enrollment into clinical trials (Baldwin, 2008). Most of the data,
however, lies in the narrative reports of the electronic medical records (EMR), and
difficulty lies in its retrieval. A study by all of the departments of family medicine at
Swedish Universities demonstrated that it was feasible to extract and store data from
patients’ medical records (Mansson, Nilsson, Bjorkelund, & Strender, 2004).
Extracting clinical data can be done through the use of natural language
processing (NLP). Natural language processing analyzes linguistics found in the narrative
text of EMRs. Using computer software, “word stemming,” “segmentation,” and
“normalization” can transform the natural text into smaller phrases where the prefixes,
suffixes, and punctuations are removed to reduce variation and then map them to a
structured coding system where they can be analyzed (Travers & Haas, 2003). There are
many challenges with NLP systems. When phrases are used with the same meaning but
typed in the notes differently, they would get coded differently. For example, “druginduced liver injury” would get coded differently than “liver injury due to drugs” even
though they have the same meaning. In addition, natural language processing systems are
quite expensive, and free-text searching methods may be just as effective (Baldwin,
2008).
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The narrative text can also be coded according to International Classification of
Diseases (ICD) codes as a way of coding narrative text. According to the Centers for
Disease Control and Prevention, the ICD-9 index has over 14,025 diagnosis codes and
3,824 procedure codes, yet there is no code for DILI (International Classification of
Diseases (ICD-10-CM/PCS) Transition- Background, 2015). Jinjuvadia, Kwan, and
Fontana previously demonstrated that even using ICD-9 codes of “acute liver injury” and
“drug poisoning” and cross linking them with the names of specific medications known
to cause DILI was unsuccessful in identifying patients with idiosyncratic DILI
(Jinjuvadia, Kwan, & Fontana, 2007). In October of 2015, the new ICD-10 index was
released. There are 69,823 diagnosis codes and 71,924 procedure codes (International
Classification of Diseases (ICD-10-CM/PCS) Transition- Background, 2015). Several of
these codes such as “toxic liver disease,” which includes “drug-induced idiosyncratic
(unpredictable) liver disease” and “hepatic failure (acute) (chronic) due to drugs,” are
specific to idiosyncratic DILI (International Classification of Diseases (ICD-10-CM/PCS)
Transition- Background, 2015). To date, there have been no studies examining the use of
ICD-10 codes to identify patients with idiosyncratic DILI. Using the more specific ICD10 coding index has the potential to be useful in screening for prospective patients with
DILI and is worth studying.
2.2 Literature Review
Recent studies have demonstrated that NLP can be a useful tool in data extraction
from narrative text. In a literature review by Warrer et al. 2015, it was demonstrated that
data mining in EMRs using free-text searching and NLP methods were capable of
identifying ADRs from medication use. The review demonstrated that more advanced
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methods like NLP identified more ADRs than manual chart reviews. However, it was
also shown that more ADRs were missed with NLP when compared with free-text
searching. This study was limited by the number of studies (seven) included in the review
and the differing study designs. (Warrer, Hansen, Juhl-Jensen, & Aagaard, 2011).
In a review of the studies included in the Warrer et al. (2011) literature review,
Honigman et al. (2001) conducted a study evaluating four different search methods to
identify ADRs. They looked at ICD-9 codes, allergy codes, free-text searching, and
computerized event monitoring systems. Of the four methods, free-text searching of notes
found in the EMR had the highest number of ADRs identified with an overall sensitivity
of 90.6%, but the positive predictive value (PPV) was relatively low at 7.2%. The
combined PPV for all four search methods was slightly higher at 7.5%. The negative
predictive value (NPV) fared much better at 99.2% (Honigman et al., 2001).
Another study included in the Warrer et al. (2011) literature review examined
strategies for identifying ADRs in the elderly. Field et al. (2004) found that when
comparing free-text searching to provider notes from an internal ADR reporting system,
manual reviews of discharge summaries, administrative incident reports, and emergency
department notes, and computer-generated signals, free-text searching was superior in
identifying ADRs. Sensitivity was lower in this study, yet the PPV was much higher at
39% and 12% respectively (Field et al., 2004).
In a study conducted by Heidemann, Law, and Fontana (2015), 101 DILI cases
were identified using a complex natural language processing algorithm to identify
retrospective patients with DILI that were attributed to eight specific drugs. A total of
2,564 potential cases were reviewed upon the use of 14 liver injury terms when cross
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linked with the names of eight specific medications (Heidemann, Law, & Fontana, 2015).
These terms included drug-induced liver toxicity, drug-induced liver injury, DILI, druginduced hepatitis, liver injury, drug-induced liver disease, hepatotoxicity, liver damage,
liver toxicity, drug-induced hepatotoxicity, drug-induced liver damage, drughepatotoxicity, and adverse liver reaction (Heidemann, Law, & Fontana, 2015). When all
14 terms were used, a total of 2,564 potential DILI cases were found; after review of all
of these, only 101 of them were true DILI. No true cases were found using the terms
drug-induced hepatotoxicity, drug-induced liver damage, drug-hepatotoxicity, or adverse
liver reaction, while liver disease yielded the most results; with 2,268 potential cases,
only 57 were true DILI. The positive predictive value was only 4% when all search terms
were used. When the four high yielding liver injury terms were used (DILI, drug-induced
liver injury, drug-induced liver toxicity and drug-induced hepatitis) the positive
predictive value increased to 64% (Heidemann, Law, & Fontana, 2015).
A study by Warrer et al. (2015) looked at clinical notes of 207 patients with type
2 diabetes mellitus who were on either one of three classes of glucose-lowering
medications. The objectives of the study were to see if there was potential using clinic
notes in the electronic medical records of patients and if there was enough information to
attribute causality of the drugs to any adverse drug reactions (ADRs). Results showed
that 163 ADRs were found. These corresponded to 27 terms grouped by organ system.
They include, but aren’t limited to increased heart rate, stomach ulcers, abdominal pain,
gastro esophageal reflux, angioedema and skin reactions. Regarding causality
assessment, 14% of the ADRs were definite, 60% were probable, and 26% were possible.
Fifteen of the 163 ADRs were unlabeled. The data from this study suggest that the use of
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clinic notes in EMRs may serve to be a useful tool in detecting new ADRs and assessing
causality (Warrer et al., 2015).
Drug-induced liver injury is the most common ADR that leads to an arrest in the
development of new medications and withdrawal of existing drugs from the market (Bell
& Chalasani, 2009). With the increase in the number of DILI cases arising from drugs
and herbal and dietary supplements (HDS) and no effective screening method to identify
a large number of patients, the current study will aim to develop a simple searching
method using free-text searching of EMRs and ICD-10 codes to identify patients with
DILI.
2.3 The DILIN Prospective Study
The DILIN network was established by the NIDDK in 2003 to help physicians
understand the etiologies, outcomes, and risk factors of patients diagnosed with DILI.
There are currently six sites enrolling patients into the DILIN study, the University of
Michigan being one of those six. The prospective arm of the study enrolls patients who
have had a liver injury due to a drug or HDS within six months of onset and follows these
subjects prospectively for either 6 or 24 months. Inclusion criteria are dependent upon lab
values and the suspected agent attributed to their liver injury. Patients who have
competing causes of liver injury such as Hepatitis A, B, C, cholangitis or alcoholic
hepatitis, or who have suffered a liver injury due to acetaminophen toxicity are excluded
from this study. A complete list of inclusion and exclusion study criteria can be found in
Appendix A.
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Traditionally, potential subjects are referred by physicians at the University of
Michigan or outside hospitals. Other methods include data-mining in EMRs for eligible
subjects. A HIPPA waiver was obtained by the University of Michigan from the
Institutional Review Board (IRB) to be able to search medical records of patients. All
subjects who participate in the study are required to sign written, informed consent that
has been approved by the IRB.
2.4 Electronic Medical Record
The University of Michigan Health System is host to 2.1 million patient visits and
47,000 hospital stays in 1000 hospital beds each year (Facts and Figures, 2015). All
encounters both inpatient and outpatient is captured in the University of Michigan Health
System’s EMR. In 2012, the University of Michigan Health System purchased an EMR
known as MiChart from Epic Systems Corporation. MiChart has the capabilities of
running customized reports based on specific search criteria such as problem lists,
emergency visit encounters, and ICD codes. Other institutionally supported tools than can
be used to generate reports using EMRs include Data Direct and The Electronic Medical
Record Search Engine (EMERSE). These enable one to generate aggregate counts and
statistics and search dictations from the EMRs for specific text and language used to
answer a specific question (Self-Serve Data Tools, 2015). Both of these tools will be used
for the purpose of this study.
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Chapter 3: Methods
3.1 Medical Record Search Techniques Using Data Direct and EMERSE
Data Direct has the capabilities of creating specific queries based on specific
filters with defining criteria such as demographics, encounters, medications administered
and ordered, labs, diagnoses, ICD codes, procedures, and problem lists. Queries were
created based upon the inclusion and exclusion criteria from the DILIN study and the use
of liver injury specific ICD-10 codes. As part of the inclusion criteria for the DILIN
prospective study, individuals must have had their liver injury from a drug or HDS within
6 months of the date of enrollment into the study. Meaning, a person who had a liver
injury greater than 6 months of the search date used would be excluded from the
prospective study.
In the initial data direct search, a query was generated that searched the problem
list and text of all inpatient encounters from June 23, 2015 and December 23, 2015. The
search was limited to living patients who were greater than two years old. Key terms
specific to DILI were searched when selecting the ICD-10 codes. For example, when
searching for DILI, the terms drug-induced liver injury, drug-induced liver disease, druginduced injury of the liver, and drug induced liver disease were the terms that resulted.
These were all coded in the same manner (<K71.9> [573.3] [E980.5]) or (K75.9). They
were used in combination with ICD-10 diagnosis codes, specific to DILI that were
inclusive of ICD-9 codes. These codes were toxic liver disease unspecified (K71.9),
inflammatory liver disease unspecified (K75.9), poisoning by unspecified drug or
medicinal substance— undetermined whether accidentally or purposely inflicted—
(E980.5) and hepatitis unspecified (573.3).
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A second technique using EMERSE was used to create a second query. This
technique used the list of specifically generated medical record numbers (MRNs) from
the data direct search and cross-linked terms specific to the diagnosis of DILI and filtered
sources in the patient’s medical record that matched these terms and highlighted the
specific terms that were searched. After examining the discharge summaries and
dictations from the last 20 patients enrolled into the DILIN study, the chart reviews of the
generated MRNs from the data direct search, and the terms used in Heidemann, Law and
Fontana (2015), a list of four terms were selected that would likely indicate a diagnosis of
DILI. These terms are as follows: drug-induced liver injury, drug-induced hepatotoxicity,
drug-induced hepatitis, and drug-induced liver toxicity. Two additional terms were added
after manual review revealed many potential cases. These terms were liver abnormalities
and DRESS (drug rash or reaction with eosinophilia and systemic symptoms). The
EMERSE search engine then integrated documents from multiple sources within
MiChart, such as dictations written by physicians, physician assistants, nurse
practitioners, residents, and any documents scanned from outside institutions, lab results,
imaging results, and procedures. Of note, the EMERSE search engine accounts for
acronyms, abbreviations, spelling mistakes, and word variations to account for error. For
example, if drug-induced liver injury is inputted into the search criteria, drug induced
liver injury, DILI, and liver injury are screened. Figure 1 shows an example of this word
segmentation.
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"drug induced
liver injury"

"DILI"

"drug-induced
liver injury"

"liver injury"

Figure 1 Word segmentation of keyword selections.
3.2 Medical Record Review
The output data from the data direct search yielded the subject’s medical record
number (MRN) that was manually entered into MiChart to review the patients’ labs,
problem list, and dictations. Each individual MRN derived from the data direct output
was examined to determine whether or not this was a potential DILI case. The problem
summary was first examined to see if there was mentioning of DILI or some variation of
DILI such as transaminitis, elevated LFTs, hepatotoxicity, or any other description
related to the possible diagnosis of DILI. It was also noted if key words that had any
relation to the words drug-induced liver injury, or relationship with the liver were
mentioned such as drug-induced pancytopenia, or traumatic brain injury. When there
were no indications or references of DILI, a quick search was initiated within the
patient’s medical record to search for terms that would likely indicate a DILI diagnosis.
Because MiChart is not sensitive, the terms were searched for individually. The terms
that were used were drug, induced, liver, and injury. If this did not yield any pertinent
results, the patients’ labs were checked to see if there were any elevations in liver
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function tests (LFTs). If there were elevations in alkaline phosphatase, total bilirubin,
alanine transaminase, or aspartate transaminase, however slight, it was documented.
Using the same MRNs, from the initial Data Direct Search, the MRNs were then
inputted into EMERSE, which pulled up and highlighted any dictation or problem noted
in the patients’ snapshot of the selected search terms mentioned in section 3.2. These
notes from each patient’s medical record were then examined further by manual chart
review to confirm a DILI diagnosis based on the inclusion and exclusion criteria for the
DILIN prospective study and reviewed by the physician investigator (PI) Robert J.
Fontana. After careful review of each EMR, each case was determined if it was
“probable,” “possible,” or non-DILI case. If the subject had met the inclusion and
exclusion criteria, the patients’ healthcare provider was contacted by the PI and the study
coordinator then contacted the patient for potential enrollment into the DILIN study.
Based on the results of the initial search, a second search using exclusion criteria
was created to decrease the amount of false positive patients. These two searches were
then compared to see if there were any significant differences in sensitivities, and positive
and negative predictive values between using only codes for DILI versus excluding
competing causes of liver injury. Competing causes of liver injury include hepatocellular
carcinomas, specified hepatitis such as A, B, C, E, autoimmune hepatitis (AIH) and HIV,
poisoning by unspecified drugs, and livers replaced by transplants. The same process of
manually reviewing each patient’s EMR was applied, and the same key terms were used
in EMERSE search for Search 2.
Terms that were similar were then grouped together to be able to identify the
codes and terms that were giving positive results. For example, Hepatitis A, B, C, E,
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HIV, alcoholic hepatitis, and AIH would all fall under the category hepatitis specified.
Other groupings included any problem summary with the word drug, induced, liver and
injury excluding drug-induced liver injury, which was categorized as DILI. If a patient’s
problem list contained multiple references to the liver or terminology used, then all
problems and diagnoses were included. If no terminology was found, but the patient had
elevated liver enzymes of any sort, they were categorized into elevated LFTs.
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Chapter 4: Results
4.1 Initial Search and Manual Chart Review
A total of 489 patients were found in the initial search when the terms druginduced liver injury, drug-induced liver disease, drug-induced injury of the liver, and
drug induced liver disease were used to search for potential patients. These were all
coded in the same manner (<K71.9> [573.3] [E980.5]) or (K75.9). After manual review
of each patient, it was found that any of these words or codes were mentioned in the
patient’s problem list, dictation notes, or any other document in the patient’s medical
record. It was also found that any elevation of LFTs yielded positive results. A list of
exact terms that were noted in the problem lists of the medical record and the
corresponding ICD-10 code can be found in Appendix B.
A manual chart review was conducted for all 489 patients. It took an estimated
time of 500 total minutes to review each medical record (1 minute per case). Because
there were 57 different ICD-10 codes that resulted from the search, similar categories
were grouped together to see where the results were coming from. Figure 2 shows the
prevalence of each term grouped into categories.
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Prevalence of Key Terms Used in
Patient's EMRs n=489
180
160

Hepatitis (specified)

156

Hepatitis (non-specified)
Drug

Number of Patients

140

Injury

120

Transaminitis

102
100

Induced
Liver

80
63

57

60

Other

0

Hepatitis C Screeening

33

40
20

DILI

17

14 12

Hepatocellular Carcinoma

20
7

12 9

7 7

Term Used

Elevated LFTs
DRESS

Figure 2 Prevalence of key terms used in patient’s EMRs.
The data in Figure 2 indicate that the greatest number of patients had a specified
hepatitis listed in their summary of problems, followed by mentioning of the words drug
and induced. Drug-induced liver injury (DILI) was only accounted for in the problem list
12 times. When a manual chart review of all 489 patients was conducted, 32 patients
were found to have a confirmed DILI diagnosis. Of the total 32 DILI cases that were
found manually, when “DILI” was mentioned in the patient’s problem list it had only
61.5% sensitivity, missing a total of 20 DILI cases.
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4.2 Search Refinement
After review of the first search method, it was concluded that there were a greater
number of terms that were included in the results of the first algorithm in proportion to
the number true positive DILI cases. There were 57 different ICD-10 codes and only 11
that corresponded with the 32 true positive cases, and only 4 different codes that
pertained to 11cases that were eligible for enrollment into the DILIN study. Therefore,
the second search was created in hopes to reduce the number of patients to review and
increase the positive predictive value (PPV). Unlike the first search where no terms or
ICD codes were excluded, the second search included a list of codes pertaining to
specified hepatitis such as A, B, C, E, AIH, HIV and alcoholic, hepatocellular
carcinomas, poisoning by unspecified drugs, and livers replaced by transplant that were
excluded from the results. The results of the second search yielded 345 patients. A
manual chart review was conducted in a similar fashion as the Search 1. This took
approximately 360 minutes to review each patient. After manual review, 23 cases of DILI
were confirmed. Once again, when “DILI” was searched in the problem list of the
medical record, only 12 cases of 23 were confirmed. Table 1 shows the sensitivities
between each search when DILI was listed in the problem list and used as the only
method of review. We can see that 20 cases were missed in Search 1 and 11 in Search 2,
indicating that this method was not sensitive. When McNemar’s chi-squared analysis was
calculated, a p-value of 0.10 resulted, indicating that there is no statistical difference in
the search sensitivities. Additionally, the PPV for each Search 1 and Search 2 were 6.5%
and 6.6%, respectively. Time to review each case (1 minute per case) was also the same.
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Table 1
Search Sensitivities Using “Drug-Induced Liver Injury” as a Key Term

Search 1
Search 2

Number of
True DILI Cases

Number of Cases
with DILI Problem
List

32
23

12
12

Cases Missed

Search
Sensitivity%
20
11

61.5
67.6

4.3 EMERSE: Review of Searches 1 and 2
After review of Heidemann, Law, and Fontana’s 2015 study on text-searching, the
four highest yielding liver terms were selected to be included in the EMERSE search
criteria. They were as follows: drug-induced liver toxicity, drug-induced liver injury,
drug-induced hepatitis, and drug induced hepatotoxicity. Additionally, based on the
confirmed DILI cases from the manual review of the data direct seach, DRESS and liver
abnormalities were selected to be part of the search as those terms yielded eight
additional positive DILI cases. Each of these six terms were inputted into the EMERSE
search engine. The medical record numbers for all 489 patients in Search 1 were copied
into the patient list. A search was then run to see which patients contained any of the six
terms. Table 2 shows the relative sensitivities and positive and negative predictive values
(NPV) for each specfic term relative to the number of potential patients. Of the 489
patients, 32 confirmed cases of DILI were found when the charts were manually
reviewed; no cases were missed. When drug-induced liver toxicity was searched, only
one patient had this listed in their medical record. Upon manual review, it was then
confirmed that the patient had drug-induced liver toxicity listed in either a dictation or
under the patient’s problem list. However, based on the number of true DILI cases that
were found via manual chart review, 31 cases of DILI were missed. Although specificity,
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PPV and NPV were 100%, the sensitivity was low at only 3.1%. Similarly when druginduced hepatotoxicity was searched, zero cases were found. Drug-induced liver injury
yielded the highest sensitivity at 43.8% and a PPV of 73.6%, followed by drug-induced
hepatitis, and liver abnormalities with sensitivies of 15.6 and 25%, and PPVs of 45.4%
and 44.4%, respectively. Though DRESS had the highest number of potential patients
with 68 mentionings, it had one of the lowest PPVs with 14.7% and a sensitivity of
31.2%. However, it did fare well with finding true DILI cases. A total of 10 cases were
found when DRESS was searched coming in closely behind drug-induced liver injury
with 14 total cases.
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Table 2
Search 1 Relative Sensitivities Using 6 Liver Injury Terms

EMERSE Term

Number
of
Potential
Patients
(using
specific
term)

Number
of True
Patients

Number
of Cases
Missed

Search
Sensitivity

Search
Specificity

PPV%

NPV%

Time
To
Review
(min)

All Terms

489

32

0

100

100

6.5

100

500

Drug-Induced
Liver Toxicity

1

1

31

3.1

100

100

100

1

Drug-Induced
Liver Injury

19

14

18

43.8

100

73.6

100

20

DRESS

68

10

22

31.2

100

14.7

100

60

Drug-Induced
Hepatitis

11

5

27

15.6

100

45.4

100

10

Liver
Abnormalities

18

8

24

25

100

44.4

100

20

Drug-Induced
Hepatotoxicity

0

0

32

0

100

0

100

0

After the initial EMERSE search was run, a second serach was run using the same
parameters in order to compare the relative sensitivies and PPVs. Results of search 2
were similar to Search 1. Drug-induced liver toxicity had the highest PPV at 100% but
only found one confirmed DILI case and had a search sensitivity of 4.3%. Drug-induced
liver injury identified the most DILI cases (12), while also having a high PPV of 85.7%
and a sensitivity of 52.1%. Liver abnormalities successfully identified eight confirmed
DILI cases and had a PPV of 72.7% and a search sensitivity of 34.7%. Similar to the
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results of Search 1, hepatotoxicity did not yield any confirmed DILI cases. Every term in
both Search 1 and Search 2 had NPVs of 100%. Table 3 shows the results of relative
sensitivities and PPVs for each search term.
Table 3
Search 2 relative sensitivities using 6 liver injury terms
EMERSE Term

Number
of
Potential
Patients
(using
specific
term)

Number
of True
Patients

Number
of Cases
Missed

Search
Sensitivity

Search
Specificity

PPV%

NPV%

Time
To
Review
Min)

All Terms

345

23

0

100

100

6.6

100

360

Drug-Induced
Liver Toxicity

1

1

22

4.3

100

100

100

1

Drug-Induced
Liver Injury

14

12

11

52.1

100

85.7

100

15

DRESS

34

3

20

13

100

8.8

100

30

Drug-Induced
Hepatitis

7

5

18

21.7

100

71.4

100

10

Liver
Abnormalities

11

8

15

34.7

100

72.7

100

10

Drug-Induced
Hepatotoxicity

0

0

23

0

100

0

100

0

4.4 Characteristics of Medical Records and DILI Cases
The 32 confirmed DILI cases were reviewed for potential enrollment into the
DILIN study. After careful review by the study coordinator and PI, it was determined that
only 11 of the 32 cases were eligble for enrollment. Of the 21 disqualified cases, four of
them were previously enrolled into the study, while four cases had liver injury onset
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greater than 6 months. Two patients were deceased, two patients refused consent, and two
patients received a liver transplant. The remaining seven cases had other competing
causes of liver injury that would thereby exclude them from participation and enrollment.
A complete list of competing causes can be found in Table 4.
Table 4
Disqualified DILI cases from enrollment into the DILIN study
Reason for Disqualification
Not Within 6 Month Time Frame
Already Enrolled
Cholangitis
Dead
Mononucleosis
Alcoholic Hepatitis
Hepatitis C
Hepatitis B
Received Liver Transplant
Refused Consent

Number of Patients
4
4
1
2
1
1
2
2
2
2

The ICD-10 codes of the remaining 11 eligible patients were also examined. The
majority of ICD-10 codes used to code these cases were found to have been
predominately from toxic liver disease (K71.9) and DRESS Syndrome (L27.0). Other
synonyms for toxic liver disease that can be included were drug induced liver disease,
drug-induced disorder of the liver, and liver disease drug induced. Synonyms for DRESS
Syndrome included acniform drug eruption, dermatitis due to drug and/or medincine
taken internally, drug rash and eruption due to drug (International Classification of
Diseases (ICD-10-CM/PCS) Transition- Background, 2015). A complete list of ICD-10
codes for the 11 elegible patients can be found in Table 5.
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Table 5
Common ICD-10 Codes for Confirmed DILI Cases
ICD-10 Code

Diagnosis

Number of Patients

R74.0

Transaminitis

1

K71.9

Toxic liver disease (DILI)

4

L27.0

DRESS Syndrome

4

K75.9

Hepatitis

1

No code: (found from labs
and dictations)

DILI

1
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Chapter 5: Discussion
5.1 Utilization of ICD-10 Codes vs Free-Text Searching
Given that DILI is difficult to diagnose, and that no objective, diagnostic test
exists to successfully determine if a patient has DILI, identifying cases for enrollment is
challenging. Over the recent years, a variety of methods have been used to search for
potential retrospective DILI cases using ICD-9 codes and natural language processing of
EMRs. To date, no studies have been done using ICD-10 codes to search for bona fide
prospective DILI cases. In the current study, a unique search method was developed
using two existing software programs at the University of Michigan to screen for
prospective DILI cases.
The first search was created using Data Direct, a software program that was
designed to deterimine the feasibilty of patients to recruit for reaearch studies. Because
the University of Michigan’s electronic medical record has over two million patients,
searching individually is burdensome for research coordinators. In addition, traditional
recruitment strategies involve the physician investigator, co-investigators to be aware of
the DILIN study. If they see any patients in clinic or while rounding that qualify for the
study, the study coordinators are notified. Little opportunity is left for the research
coordinator to actively recruit patients. Data Direct is a self-serve tool that allows the
coordinator to input specific cirteria and parameters into the seach engine to populate a
list of MRNs of indivuduals who meet the search criteria (Self-Serve Data Tools, 2015).
While NLP can serve as a useful tool, generalizability is often prevented due to
misspellings and synonyms of the same word. In addition, it also involves complex
algorithms and can be very expensive (Hersh, Campbell, & Malveau, 1997). The use of
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ICD-10 codes provides for a more specific and generalizable way to search specifically
for diagnosed DILI cases. With the new ICD-10 coding system, there are now specific
codes for DILI. Codes such as toxic liver disease (K71.9) include drug-induced
idiosyncratic (unpredictable) liver disease and hepatic failure (acute) (chronic) due to
drugs and are specific to idiosyncratic DILI (International Classification of Diseases
(ICD-10-CM/PCS) Transition- Background, 2015). Searching specifically for this code,
as opposed to text, eliminates idioms, misspellings, and other syntax errors.
Over a 6-month window, an initial search was created (Search 1). There were 489
potential DILI cases that were identified. Of these 489 cases, only 32 were true DILI
cases after manual review. After careful review of the ICD-10 codes, however, only 12
cases were coded using K71.9, resulting in a PPV of 2.5% when all 489 cases were
considered. When all codes were used for qualifying DILI cases, the PPV value increased
to 6.5%, suggesting that while the code for DILI is specific, not all cases were being
coded correctly or including the K71.9 code.
A second observation was that most of the cases that resulted from the initial
search were non-DILI cases. Manual review of these cases determined that the search
was picking up on terms that related to the words drug, induced, liver and injury as
shown in Figure 2. For example, patients with any type of hepatitis who were greater than
two years old that had a hospital visit in the last six months were included in the results of
the 489 potential patients. This amounted to 156 cases, all of which were excluded. The
high number of non-DILI cases suggests that the search was too senstive in efforts to
identify DILI cases.
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Search 1 resulted in a high number of potential DILI cases that took
approxamately 500 minutes of review time. Because of the amount of time that it took to
manually review, a second search (Search 2) was created using the same parameters with
excluding diagnoses. After review of Search 1, ICD-10 codes for all forms of hepatitis,
(with the exception of non-specific hepatitis), liver transplant, and hepatocellular
carcinoma were excluded in effort to create a less sensitive test and cut down on review
time. A total of 345 potential patients resulted in Search 2, with 23 total DILI cases. The
PPV improved slightly from 6.5% to 6.6% and 12 cases were identified using K71.9.
Time to review decreased from 500 minutes to 360 minutes. Similar to Search 1, Search
2 also showed to be too sensitive and including exclusion parameters made no difference
identifying bona fide DILI cases. More DILI cases were also missed using Search 2
suggesting that actual DILI cases also contain ICD-10 codes that were on the exclusion
list. For example, a subject who was suspected to have DILI but also had acute hepatitis
B would have been excluded in the search if hepatitis B (B19.10) was coded and toxic
liver disease (K71.9) was not (International Classification of Diseases (ICD-10-CM/PCS)
Transition- Background, 2015).
A similar concept was applied using a second search method. EMERSE is an
electronic medical record search engine that allows one to search through a patients chart
for specfic words or phrases. Unlike traditional NLP where grammatical errors and
synonyms must be broken down and accounted for, EMERSE automatically accounts for
these, making it easier to search and identify eligible patient. Additionally, each inputted
word is highlighted and the specific lab, image or dictation is pulled up directly. Figure 3
shows an example of the search output. When each individual mosaic is selected, it
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navigates directly to the dictation or section the the EMR containing the highlighted term.
This makes it conveinent for researchers to be brought directly to the source of the
information instead of having to manually screen through their entire chart.

Figure 3
Output search results using free-text searching
In similar fashion, two searches were run using EMERSE. Search 1 contained the
list of 489 MRNs and Search 2 contained 345 MRNs. The same keywords were selected
with both searches. When comparing the two searches, for all terms, the PPV was higher
even though the total amount of identified cases was less. Having less false positives will
increase the PPV and cut down on review time. In Tables 2 and Table 3, the number of
potential patients corresponding with each term were significantly reduced, making it
much easier to identify DILI cases.
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On a term-by-term basis, for both searches 1 and 2, drug-induced liver injury had
the highest PPV at 73.6% and 85.7%, while drug-induced hepatotoxcity had the lowest at
0%, respectively. This indicates that drug-induced liver injury is a better predictive term
in identifying bona fide DILI cases, while drug-induced hepatotoxcity does not. In
relation to the potential amount of patients identfied with each term, “drug-induced liver
injury” also was the most sensitive, and it correctly identified patients with DILI better
than drug-induced liver toxicity, DRESS, drug-induced hepatitis, liver abnormalities, and
drug-induced hepatotoxicity.
When comparing ICD-10 searching methods in Data Direct with free-text
searching in EMERSE, free-text searching was shown to be superior to the use of ICD-10
codes. In Searches 1 and 2 using ICD-10 codes, the PPVs were 6.5% and 6.6%. In
Searches 1 and 2 using free-text methods, all PPVs were greather than 6.6% showing the
superiority of free-text searching over the use of ICD-10 codes. Of note, because some
patients contained more than one of the selected terms, there is no way to determine the
relative PPV for all of the terms combined versus all codes used. However, based on each
individual result, we can see that the PPV was higher in every circumstance. Negative
predictive values were equall across the board and well as the specificity.
5.2 Possible Reasons for Low Numbers of Cases
There are 69,823 diagnosis codes and 71,924 procedure codes listed in the ICD10 index (International Classification of Diseases (ICD-10-CM/PCS) TransitionBackground, 2015). Because it is up to the physicians, nurses, and medical assistants to
update the patients problem list and code each diagnosis, there is a lot of room for
variabilty and inconsistencies in coding. For example, a patient who was seen in the
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hospital and found to have DILI would also have elevated liver enzymes by the nature of
the disease. This can be specifically coded as DILI, but it would not be incorrect to code
it as elevated LFTs, hepatitis unspecfied, or transaminitis. This makes it difficult to
search using only ICD-10 codes for DILI. Additional codes for hepatitis or transaminitis
can be used; however this will likely increase the number of potential patients to screen
and increase the amount of time spent manaully reviewing charts.
Differential diagnoses also cloud the free-text search. Most of the time when a
patient arrives, they are not diagnosed immediately. There are instead multiple
possibilities to consider, second opinions, consultations, and follow-ups. All of which are
dictated in the patient’s medical chart. The following information from a patient’s
medical record can be examined to demonstrate:
A 52 year old menopausal woman with history of polycystic kidney and liver
disease who presents with a 2-week history of progressive nausea, abdominal
pain, pruritis and found to have grossly elevated LFTs. Differential diagnosis
includes drug-induced liver injury in the setting of recent herbal supplements with
black cohash as a substance notorious for hepatotoxicity, autoimmune hepatitis
given positive antinuclear antibodies (ANA+) and family history, as well as viral
hepatitis. No acute portal clot on right upper quadrant (RUQ) ultrasound. No
known cardiac history, so less suspicious for congestive hepatopathy picture.
In this real-life case study, multiple forms of liver disease are being considered as
we can see from this dictation. In the search algorithm that was created in the current
study, drug-induced liver injury and hepatotoxcity would be a positive hit and would be
highlighed in the results as a potential DILI case. Now if the diagnosis did not end up
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being DILI and was instead AIH, then this would end up being a false positive,
contributing to a lower amount of true DILI cases.
The third and final reason for low numbers of DILI cases is that DILI is a rare
disease affecting roughly 14 per 100,000 people (Bell & Chalasani, 2009). There are
about 2 million outpatient visits and 97,000 inpatient stays per year . Because patients
usually have more than one outpatient visits and data have shown that the majority of
DILI cases are hospitalized, it is assumed that the number of patients seen at the
Univeristy of Michigan on a yearly basis is somewhere between 97,000 and 2 million.
Therefore, the 32 identified potential DILI cases are actually comparable to the
prevelence of 14 in 100,000. It is recommended that in the future, patient charts are
updated to accurately reflect past and present problems, and only specific DILI terms are
used to search for potential patients. Even if some cases are missed, several hours of
review time will be saved.
5.3 Study Limitations and Recommendations for Future Research
Several limitations exist with using both ICD-10 codes and free-text searching to
screen for patients with DILI. Limitations of this study included that the free-text search
was dependent upon the ICD-10 search. In other words, to get the list of MRNs to input
into EMERSE to screen, they must have first been obtained from the Data Direct search.
If the ICD-10 codes are not being picked up by the first search, then there is less potential
for positive hits in the free-text search. Secondly, this study was also limited to the
University of Michigan Hospitals and Health Systems. While other insitutions may use
EPIC for EMRs, both Data Direct and EMERSE are unique to the University of
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Michigan. Therefore, this study may be limited to study coordintors at the University of
Michigan.
Future research is needed to first determine if similar tools exist at other
institutions, particularly at the enrolling DILIN sites. If such tools exist, a similar study
would need to be conducted to determine if simlar results are found and to confidently
say this is a useful method of recruitment. We will also need to evaluate its long term
success and probability of identifying DILI cases. Because enrollment is ongoing, we
will need to observe the number of cases enrolled into the the DILIN study from this
search over an extended timeframe. We can then objectively compare current enrollment
rates to prospective rates from the development of this search. Using this method going
forward, there should be less cases to review since all cases within the 6 month time
frame were already reviewed. When using a shorter window, the amount of cases to
review will be more managebale.
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Chapter 6: Conclusion
The current study developed a simple searching method using free-text searching
of EMRs and ICD-10 codes to identify patients with DILI. In total, 32 cases of DILI were
identified using ICD-10 codes, 11 of which were eligible for enrollment into the
prospective DILIN study. The code for toxic liver disease, (K71.9) had the best PPV in
identifying bona fide DILI cases with ICD-10 searching, while drug-induced liver injury
had the highest PPV when using free-text searching methods. Refinements made to the
initial screen, by excluding codes pertaining to competing causes of liver injury, did not
improve the number of cases identified. It did reduce the total review time, but was still
proportional in terms of time to review per patient. Refinement of the search will be
made, and enrollment rates will be examined going forward to determine the usefulness
of this tool.
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Appendix A: DILI Inclusion and Exclusion Criteria
Liver Disease DILI Case Definition
Inclusion Criteria:
 Age > 2 years at enrollment into study.
 Evidence of liver injury that is known or suspected to be related to
consumption of drug or CAM product in 6-month period prior to enrollment.
 Known chronic hepatitis B or C infection defined by detectable HBsAg or
HCV RNA for at least 6 months prior to DILI onset
 Written informed consent from patient or patient’s legal guardian.
 Documented clinically important DILI, defined as any of the following:
o ALT or AST > 5 x ULN or ALP > 2 x ULN confirmed on at least 2
consecutive blood draws in patients with previously normal values.
o If baseline ALT, AST, or ALP elevated, ALT or AST > 5 x BL or ALP > 2
x BL on at least 2 consecutive blood draws. Baseline is average of 2
measurements performed during 12-month period prior to starting
implicated medication.
o Any elevation of ALT, ALP, or AST, associated with (a) increased total
bilirubin [≥ 2.5 mg/dL], in absence of prior diagnosis of liver disease,
Gilbert’s Syndrome, or evidence of hemolysis or (b) coagulopathy with
INR > 1.5 in absence of Coumadin therapy or vitamin K deficiency.
Exclusion Criteria:
Patients with any of the following will not be eligible:





Competing cause of acute liver injury such as hepatic ischemia that is felt
by investigator to be primary reason for observed liver injury and
supported by laboratory tests, serologies, liver biopsy, or radiology.
Known, pre-existing autoimmune hepatitis, primary biliary cirrhosis,
primary sclerosing cholangitis, or other chronic biliary tract disease that
may confound ability to make a diagnosis of DILI.
Acetaminophen hepatotoxicity.
Liver/allogeneic bone marrow transplant prior to development of drug- or
CAM-induced liver injury (The DILIN Research Group, 2015).
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Appendix B: Result of ICD-10 Codes from Data Direct Search
ICD 10
code
B15.9

B19.10

B19.2
B27.9

C22.0

C78.7

D18.09

Terminology
Acute hepatitis Acute type A
viral hepatitis, Hepatitis A,
Viral Hepatitis A
Cirrhosis due to hepatitis B,
Cirrhosis of liver due to
Hepatitis B, Cirrhosis,
Hepatitis B, Type B Viral
Hepatitis
Hepatitis C, Viral Hepatitis C
EBV, infectious
mononucleosis, Epstein barr
virus disease
Liver cell carcinoma,
hepatocellular carcinoma,
hematoma
Secondary malignant
neoplasm of liver and
intrahepatic bile duct
Hemangioma liver

ICD 10
code
K75.9

Nonalcoholic fatty liver
disease, fatty liver, fatty
liver disease

K76.6
K76.89

Portal hypertension
Lesion of liver, liver nodule

K76.9

Liver disease, disease of
liver

K83.0

Cholangitis

K85.3

Drug induced acute
pancreatitis
Generalized skin eruption
due to drugs and
medicaments taken
internally, drug rash, due to
drug rash due to drugs and
medicaments, eruption due
to drug
Drug-induced gout

Other drug-induced
pancytopenia

L27.0

D69.59

Drug induced
thrombocytopenia
Drug induced neutropenia

M10.232

Eosinophil count raised,
Eosinophilia, allergic,
DRESS syndrome
Drug induced neutropenia,
Neutropenia, drug induced
Drug-induced thyroiditis

R16.0

D72.1

D70.2
E06.4

Hepatitis, inflammatory
disease of live

K76.0

D61.811

D70.2

Terminology

N17.9

R73.9
R74.0

Injury kidney, no traumatic,
acute, acute renal failure
Liver mass

Steroid induced
hyperglycemia
Elevated ALT, elevated
alanine aminotransferase
(ALT), elevated
transaminase, transaminitis,
increased transaminase
levels
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code
E09.65

Terminology
Drug or chemical induced
diabetes mellitus with
hyperglycemia
Hyperbilirubinemia
Other psychoactive substance
abuse, uncomplicated

ICD 10
code
S24.109

Terminology
Injury of thoracic spinal
cord

G21.11

neuroleptic induced due to
drugs

T39.1X2

G21.19

drug induced Parkinsonism

T50.2X5A

G25.1

Drug-induced tremor

T50.901A

G25.61

Drug induced tics

T50.902A

G62.0

Drug-induced
polyneuropathy

T50.905A

I95.2

Hypotension due to drugs

T88.7

K25.9

gastric ulcer due to drugs

T88.7XXA

K70.10

Acute alcoholic hepatitis,
Acute alcoholic liver disease,
Alcoholic hepatitis,
Alcoholic hepatitis, acute,
Alcoholic hepatitis, chronic,
Chronic alcoholic hepatitis
Alcoholic cirrhosis w ascites,
Ascites due to alcoholic

V42.7

Rotator cuff injury
Hyperglycemia due to
steroid induced diabetes
mellitus, steroid-induced
osteopenia, corticosteroids
adverse reaction
Intentional acetaminophen
overdose, poisoning by 4aminophenol derivatives
intentional self-harm
Adverse effect of carbonicanhydrase inhibitors,
benzothiadiazides and other
diuretics, initial encounter
Poisoning by unspecified
drugs, medicaments and
biological substances,
accidental (unintentional),
initial encounter
Poisoning by unspecified
drugs, medicaments and
biological substances,
intentional self-harm, initial
encounter
Adverse effect of
unspecified drugs,
medicaments and biological
substances, initial encounter
Unspecified adverse effect
of drug or medicament
Unspecified adverse effect
of drug or medicament,
initial encounter
Liver replaced by transplant

Z13.850

Traumatic brain injury

E80.6
F19.10

K70.31

S43.42
T38.0X5A
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Using ICD-10 codes and free-text searching to identify patients with DILI
ICD 10
code
K71.0

K71.9

K72.0

K75.4

Terminology
Toxic liver disease with
cholestasis, Drug-induced
cholestatic hepatitis
Toxic liver disease,
unspecified, Drug induced
liver disease, Drug-induced
disorder of liver, Liver
disease, drug induced · Toxic
liver disease · Degeneration,
degenerative liver (diffuse)
K76.89 toxic (acute)
Acute and sub-acute hepatic
failure, Acute hepatic failure,
Acute necrosis of liver
Autoimmune hepatitis

ICD 10
code
Z71.7

Terminology

Z72.89

Drug seeking behavior

Z91.81

At risk for fall injury

HIV
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